Gonadal Dysgenesis and Gynecologic Cancer

Division of Gynecologic Oncology, University of Minnesota Department of Obstetrics, Gynecology, Women's Health, Minneapolis, Minnesota, USA.
Obstetrics and Gynecology (Impact Factor: 5.18). 08/2010; 116 Suppl 2(2):550-2. DOI: 10.1097/AOG.0b013e3181e4bfe9
Source: PubMed


Gonadal dysgenesis encompasses a variety of sexual differentiation disorders. Within this population of patients, there is an increased risk of gonadal tumor formation.
In this case series of three patients, two with Swyer's syndrome (complete gonadal dysgenesis) and one with mosaic Turner's syndrome, three separate histologic subtypes of tumors were identified: dysgerminoma, seminoma, and gonadoblastoma. The patients with dysgerminoma and seminoma had regular menses and were without recurrent disease. We recommend that the patient with gonadoblastoma start on hormone therapy.
Once the diagnosis of gonadal dysgenesis is made, prophylactic gonadectomy should be performed owing to the probability of malignant transformation. These patients illustrate the potential different presentations with gonadal dysgenesis and the importance of complete evaluation of patients with primary amenorrhea.

10 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Under the current deep submicron technology, the capacitance extraction of interconnects has become more and more important and more coupling capacitances need to be extracted accurately rather than those related with a single master net for high-precision time verification. Therefore, for a simulated structure, IV voltage must be set on different conductors one by one and the corresponding linear system with multiple right-hand sides (RHS) should be solved efficiently. In this paper, direct equation solving techniques are presented to extract the parasitic capacitances with multiple master conductors. Combined with the quasi-multiple medium (QMM) technology, our method exploits the sparsity of the resulted coefficient matrix and is very suitable for the problem with multiple RHS. The experiments on actual interconnect structures have shown that our method is several times faster than the conventional GMRES solver, while preserving the computational accuracy.
    Solid-State and Integrated Circuits Technology, 2004. Proceedings. 7th International Conference on; 11/2004
  • [Show abstract] [Hide abstract]
    ABSTRACT: Ovarian germ cell malignancies are rare tumors primarily affecting young women of reproductive age. Advances in modern therapy have allowed patients with primitive germ cell tumors (dysgerminoma, yolk sac tumor, choriocarcinoma and embryonal carcinoma) and biphasic or triphasic teratomas (dermoid cyst and immature teratoma) to preserve fertility and to be treated successfully, even when the disease is advanced. Monodermal teratomas and somatic-type tumors associated with biphasic and triphasic teratomas are even less common in occurrence and have a relatively good success rate, if limited to the ovary (stage I) when diagnosed, but have a poor overall survival when diagnosed in advanced stages. This article will review background information regarding these tumors, and advances in their diagnosis and management.
    Expert Review of Obstetrics &amp Gynecology 02/2011; 6(2):163-178. DOI:10.1586/eog.10.80
  • [Show abstract] [Hide abstract]
    ABSTRACT: Conservative surgery followed by platinum-based chemotherapy is considered the standard approach for pure ovarian dysgerminoma (POD), except for correctly staged IA patients. The aim of study was to evaluate the outcome of IA POD patients with incomplete surgical staging in order to define the proper management. Data concerning primary treatment and recurrence were reviewed for 26 patients with stage IA POD treated in MITO (Multicenter Italian Trials in Ovarian Cancer) centers. Median age was 22.5years. Primary surgery was fertility sparing for 17 patients (65.4%) and radical surgery was performed in 9 patients due to older age or gonadal dysgenesis. Only five patients (19.2%) had complete surgical staging; 38.5% had lymph node dissection, 46.2% had peritoneal biopsies and/or omentectomy and 65.4% had peritoneal washing. Seven patients received adjuvant chemotherapy. Overall recurrence rate was 11.5%: all recurrences occurred in the group submitted to incomplete staging procedure. No patients treated with adjuvant chemotherapy relapsed. One patient had pelvic recurrence, one patient relapsed in the abdomino-pelvic peritoneum and lymph nodes and the third patient showed a peritoneum, lymph nodal and residual ovary relapse. All patients with recurrence were cured by salvage therapy: 2 patients were treated with surgery plus chemotherapy and one only with chemotherapy. After a median follow-up of 100months all patients are alive without evidence of disease. Six patients opted for conception and delivered healthy infants, two with IVF with donor oocyte. IA POD prognosis is excellent. Conservative surgery with a complete surgical staging is the gold standard. Patients with incomplete staging could undergo surgical restaging or surveillance. Chemotherapy should be reserved to relapse with excellent chances of therapeutic success.
    Gynecologic Oncology 05/2011; 121(2):280-4. DOI:10.1016/j.ygyno.2011.01.006 · 3.77 Impact Factor
Show more

Similar Publications